Hims & Hers Health (HIMS) Stock Price, Quote, News & History | Benzinga

Hims & Hers Health Inc (HIMS) Stock Price, Quote, News & History

HIMSNYSE

Trade with Public

Trade with Public

$28.96

-1.00-3.35%

Last update: Aug 13, 12:32 PM

Earnings: Q2 2026 Earnings were released on Mon Aug 10th, after the market close

Conference Call: The most recent conference call started at 5:00 PM, 3 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$29.74

Close

-

Volume / Avg.

6.94M / 17.76M

Day Range

$28.54 - $30.10

52 Wk Range

13.74 - 65.30

Market Cap

$6.76B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

44

Short Interest

32.05%

Days to Cover

3.71

Recent Hims & Hers Health, Inc. News

Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst

HIMS stock edges lower after mixed Q2 results. Needham analyst maintains Buy rating, raises PT to $42. Company's revenue up 38.2% YoY.

Priya Nigam

Why Is Hims & Hers Health Stock Falling Tuesday?

Hims & Hers stock falls after Q2 earnings miss estimates despite beating revenue targets. Here is what drove the stock down.

Kaustubh Bagalkote

OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26 guidance. Other stocks also down in pre-market.

Avi Kapoor

Rocket Lab USA, Hims & Hers, AST SpaceMobile, Archer Aviation and Plug Power: Why These 5 Stocks Are on Investors' Radars Today

RKLB, HIMS, ASTS, ACHR, PLUG were among the stocks seen trending on Monday, Aug. 10, 2026.

Shivdeep Dhaliwal

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details

Hims & Hers posted Q2 results - here are the details you need to know.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

263.45M

Investing Cash Flow (TTM)

-901.98M

Financing Cash Flow (TTM)

127.35M

Free Cash Flow (TTM)

61.63M

Capital Expenditure (TTM)

-201.82M

Net Change in Cash (TTM)

-511.19M

Analyst Trends and Forecast

1

2

Apr

2

5

May

1

Jun

1

3

Jul

1

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.70B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.87

PB Ratio (TTM)

21.58

Earnings Yield % (TTM)

-2.14%

Earnings Yield % (FWD)

-1.69%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

120.26

Book Value / Share

$1.39

Company Debt

Total Debt

$1.37B

LT Debt

$1.37B

LT Debt Issuance (TTM)

$390.43M

LT Debt Repayment (TTM)

-

Total Cash

$609.81M

Debt to Equity

4.77

Issuance of Debt (TTM)

$390.43M

Repayment of Debt (TTM)

-

Key Statistics

Open

$29.74

Close

-

Volume / Avg.

6.94M / 17.76M

Day Range

$28.54 - $30.10

52 Wk Range

13.74 - 65.30

Market Cap

$6.76B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

44

Short Interest

32.05%

Days to Cover

3.71

About

Sector

Health Care

Industry

Health Care Providers & Services

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Hims & Hers Health (HIMS) stock?

A

You can purchase shares of Hims & Hers Health (NYSE:HIMS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Hims & Hers Health (HIMS) competitors?

A

Other companies in Hims & Hers Health’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).

Q

What is the forecast, or price target, for Hims & Hers Health (HIMS) stock?

A

Hims & Hers Health has a consensus price target of $31.07.

Q

What is the current price for Hims & Hers Health (HIMS)?

A

The stock price for Hims & Hers Health (NYSE: HIMS) is $28.965 last updated August 13, 2026 at 12:32 PM EDT.

Q

Does Hims & Hers Health (HIMS) pay a dividend?

A

There are no upcoming dividends for Hims & Hers Health.

Q

When is Hims & Hers Health (NYSE:HIMS) reporting earnings?

A

Hims & Hers Health does not have any upcoming earnings scheduled.

Q

Is Hims & Hers Health (HIMS) going to split?

A

There is no upcoming split for Hims & Hers Health.

Q

What sector and industry does Hims & Hers Health (HIMS) operate in?

A

Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.